Corrigendum to Normalization of data for viability and relative cell function curves

Most read articles by the same author(s)

• Wanda van der Stel, Giada Carta, Julie Eakins, Johannes Delp, Ilinca Suciu, Anna Forsby, Andrea Cediel-Ulloa, Kristina Attoff, Florentina Troger, Hennicke Kamp, Iain Gardner, Barbara Zdrazil, Martijn J. Moné, Gerhard F. Ecker, Manuel Pastor, Jose Carlos Gómez-Tamayo, Andrew White, Erik H. J. Danen, Marcel Leist, Paul Walker, Paul Jennings, Susanne Hougaard Bennekou, Bob van de Water, New approach methods (NAMs) supporting read-across: Two neurotoxicity AOP-based IATA case studies , ALTEX - Alternatives to animal experimentation: Vol. 38 No. 4 (2021)
• Troy Seidle, Helena Kandarova, Thomas Hartung, Marcel Leist, Winfried Neuhaus, Horst Spielmann, Costanza Rovida, Open letter: Selection of a new Executive Director of the European Chemicals Agency (ECHA) provides an opportunity for the EU to lead in the field of chemicals management and implementation of innovative science , ALTEX - Alternatives to animal experimentation: Vol. 39 No. 1 (2022)
• David Pamies, Marcel Leist, Sandra Coecke, Gerard Bowe, David G. Allen, Gerhard Gstraunthaler, Anna Bal-Price, Francesca Pistollato, Rob B. M. de Vries, Helena T. Hogberg, Thomas Hartung, Glyn Stacey, Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0) , ALTEX - Alternatives to animal experimentation: Vol. 39 No. 1 (2022)
• Giorgia Pallocca, Costanza Rovida, Marcel Leist, On the usefulness of animals as a model system (part I): Overview of criteria and focus on robustness , ALTEX - Alternatives to animal experimentation: Vol. 39 No. 2 (2022)
• Giorgia Pallocca, Martijn J. Moné, Hennicke Kamp, Mirjam Luijten, Bob van de Water, Marcel Leist, Next-generation risk assessment of chemicals – Rolling out a human-centric testing strategy to drive 3R implementation: The RISK-HUNT3R project perspective , ALTEX - Alternatives to animal experimentation: Vol. 39 No. 3 (2022)
• Giorgia Pallocca, Marcel Leist, On the usefulness of animals as a model system (part II): Considering benefits within distinct use domains , ALTEX - Alternatives to animal experimentation: Vol. 39 No. 3 (2022)
• Hagen Eike Keßel, Stefan Masjosthusmann, Kristina Bartmann, Jonathan Blum, Arif Dönmez, Nils Förster, Jördis Klose, Axel Mosig, Melanie Pahl, Marcel Leist, Martin Scholze, Ellen Fritsche, The impact of biostatistics on hazard characterization using in vitro developmental neurotoxicity assays , ALTEX - Alternatives to animal experimentation: Vol. 40 No. 4 (2023)
• Costanza Rovida, Francois Busquet, Marcel Leist, Thomas Hartung, REACH out-numbered! The future of REACH and animal numbers , ALTEX - Alternatives to animal experimentation: Vol. 40 No. 3 (2023)
• Walter Zobl, Annette Bitsch, Jonathan Blum, Jan J. W. A. Boei, Liliana Capinha, Giada Carta, Jose V. Castell, Enrico Davoli, Christina Drake, Ciaran P. Fisher, Muriel M. Heldring, Barira Islam, Paul Jennings, Marcel Leist, Damiano Pellegrino-Coppola, Johannes P. Schimming, Kirsten E. Snijders, Laia Tolosa, Bob van de Water, Barbara M. A. van Vugt-Lussenburg, Paul Walker, Matthias M. Wehr, Lukas S. Wijaya, Sylvia E. Escher, Protectiveness of NAM-based hazard assessment – which testing scope is required? , ALTEX - Alternatives to animal experimentation: Vol. 41 No. 2 (2024)
• Anna-Katharina Holzer, Nadine Dreser, Giorgia Pallocca, Aswin Mangerich, Glyn Stacey, Michele Dipalo, Bob van de Water, Costanza Rovida, Petra H. Wirtz, Barbara van Vugt, Giulia Panzarella, Thomas Hartung, Andrea Terron, Iris Mangas, Matthias Herzler, Philip Marx-Stoelting, Sandra Coecke, Marcel Leist, Acceptance criteria for new approach methods in toxicology and human health-relevant life science research – part I , ALTEX - Alternatives to animal experimentation: Vol. 40 No. 4 (2023)